{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:42:48Z","timestamp":1792086168632,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2016-0621"],"award-info":[{"award-number":["PICT 2016-0621"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13071-019-3362-6","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T13:02:41Z","timestamp":1553518961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide"],"prefix":"10.1186","volume":"12","author":[{"given":"Edwin F.","family":"S\u00e1nchez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana G.","family":"Corigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina M.","family":"Albarrac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria A.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Legarralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda A.","family":"Bengoa-Luoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"3362_CR1","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.130.5.2407","volume":"130","author":"LH Kasper","year":"1983","unstructured":"Kasper LH, Crabb JH, Pfefferkorn ER. Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. J Immunol. 1983;130:2407\u201312.","journal-title":"J Immunol"},{"key":"3362_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0020-7519(01)00261-2","volume":"31","author":"C Lekutis","year":"2001","unstructured":"Lekutis C, Ferguson DJ, Grigg ME, Camps M, Boothroyd JC. Surface antigens of Toxoplasma gondii: variations on a theme. Int J Parasitol. 2001;31:1285\u201392.","journal-title":"Int J Parasitol"},{"key":"3362_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/infdis\/157.5.979","volume":"157","author":"IA Khan","year":"1988","unstructured":"Khan IA, Eckel ME, Pfefferkorn ER, Kasper LH. Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J Infect Dis. 1988;157:979\u201384.","journal-title":"J Infect Dis"},{"key":"3362_CR4","first-page":"214","volume-title":"Genetically engineered plants as a source of vaccines against wide spread diseases","author":"M Clemente","year":"2014","unstructured":"Clemente M. Plant-based vaccines against toxoplasmosis. In: Rosales-Mendoza S, editor. Genetically engineered plants as a source of vaccines against wide spread diseases. New York: Springer International Publishing; 2014. p. 214\u201341."},{"key":"3362_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-319-90137-4_4","volume-title":"Prospects of plant-based vaccines in veterinary medicine","author":"VA Sander","year":"2018","unstructured":"Sander VA, Angel SO, Clemente M. A comprehensive review of Toxoplasma gondii biology and host-cell interaction: challenges for a plant-based vaccine. In: MacDonald J, editor. Prospects of plant-based vaccines in veterinary medicine. Basel: Springer International Publishing; 2018. p. 89\u2013120."},{"key":"3362_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1756-3305-7-180","volume":"7","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors. 2014;7:180.","journal-title":"Parasit Vectors"},{"key":"3362_CR7","first-page":"1","volume":"18","author":"YZ Wu","year":"1998","unstructured":"Wu YZ, Zhu XH. The cognition and understanding for study on epitopic biology. Cur Immunol. 1998;18:1\u20132.","journal-title":"Cur Immunol"},{"key":"3362_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00436-015-4824-1","volume":"115","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang G, Cai J, Yin H. Review on the identification and role of Toxoplasma gondii antigenic epitopes. Parasitol Res. 2016;115:459\u201368.","journal-title":"Parasitol Res"},{"key":"3362_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/0161-5890(94)90054-X","volume":"31","author":"I Godard","year":"1994","unstructured":"Godard I, Estaquier J, Zenner L, Bossus M, Auriault C, Darcy F, et al. Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Mol Immunol. 1994;31:1353\u201363.","journal-title":"Mol Immunol"},{"key":"3362_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.exppara.2006.02.005","volume":"114","author":"H Siachoque","year":"2006","unstructured":"Siachoque H, Guzman F, Burgos J, Patarroyo ME, Gomez Marin JE. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Parasitol. 2006;114:62\u20135.","journal-title":"Exp Parasitol"},{"key":"3362_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.exppara.2009.06.017","volume":"123","author":"N Cardona","year":"2009","unstructured":"Cardona N, de-la-Torre A, Siachoque H, Patarroyo MA, Gomez-Marin JE. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis. Exp Parasitol. 2009;123:199\u2013202.","journal-title":"Exp Parasitol"},{"key":"3362_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1756-3305-6-125","volume":"6","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang G, Zhang D, Yin H, Wang M. Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1. Parasit Vectors. 2013;6:125.","journal-title":"Parasit Vectors"},{"key":"3362_CR13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","volume":"146","author":"RT Gazzinelli","year":"1991","unstructured":"Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol. 1991;146:286\u201392.","journal-title":"J Immunol"},{"key":"3362_CR14","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","volume":"164","author":"H Kang","year":"2000","unstructured":"Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol. 2000;164:2629\u201334.","journal-title":"J Immunol"},{"key":"3362_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1365-2567.1996.d01-697.x","volume":"88","author":"E Rom\u00e1n","year":"1996","unstructured":"Rom\u00e1n E, Moreno C. Synthetic peptides non-covalently bound to bacterial hsp 70 elicit peptide-specific T-cell responses in vivo. Immunology. 1996;88:487\u201392.","journal-title":"Immunology"},{"key":"3362_CR16","first-page":"451","volume":"77","author":"K Suzue","year":"1996","unstructured":"Suzue K, Young RA. Heat shock proteins as immunological carriers and vaccines. EXS. 1996;77:451\u201365.","journal-title":"EXS"},{"key":"3362_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0161-5890(99)00136-4","volume":"36","author":"AI Rico","year":"1999","unstructured":"Rico AI, Angel SO, Alonso C, Requena JM. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol. 1999;36:1131\u20139.","journal-title":"Mol Immunol"},{"key":"3362_CR18","doi-asserted-by":"publisher","first-page":"e21231","DOI":"10.1371\/journal.pone.0021231","volume":"6","author":"MG Corigliano","year":"2011","unstructured":"Corigliano MG, Maglioco A, Lagu\u00eda Becher M, Goldman A, Mart\u00edn V, Angel SO, et al. Plant Hsp90 proteins interact with B-cells and stimulate their proliferation. PLoS One. 2011;6:e21231.","journal-title":"PLoS One"},{"key":"3362_CR19","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1016\/j.vaccine.2013.09.047","volume":"31","author":"MG Corigliano","year":"2013","unstructured":"Corigliano MG, Fenoy I, Sander V, Maglioco A, Goldman A, Clemente M. Plant heat shock protein 90 as carrier-adjuvant for immunization against a reporter antigen. Vaccine. 2013;31:5872\u20138.","journal-title":"Vaccine"},{"key":"3362_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/biot.201400742","volume":"10","author":"RM Albarrac\u00edn","year":"2015","unstructured":"Albarrac\u00edn RM, Becher ML, Farran I, Sander VA, Corigliano MG, Y\u00e1cono ML, et al. The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83-kDa improves expression levels in tobacco chloroplasts. Biotechnol J. 2015;10:748\u201359.","journal-title":"Biotechnol J"},{"key":"3362_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1472-6750-10-52","volume":"10","author":"M Lagu\u00eda-Becher","year":"2010","unstructured":"Lagu\u00eda-Becher M, Mart\u00edn V, Kraemer M, Corigliano M, Yacono ML, Goldman A, et al. Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol. 2010;10:52.","journal-title":"BMC Biotechnol"},{"key":"3362_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1385\/MB:30:1:041","volume":"30","author":"M Clemente","year":"2005","unstructured":"Clemente M, Curilovic R, Sassone A, Zelada A, Angel SO, Mentaberry AN. Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity. Mol Biotechnol. 2005;30:41\u201350.","journal-title":"Mol Biotechnol"},{"key":"3362_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0165-2478(01)00179-1","volume":"76","author":"P Echeverria","year":"2001","unstructured":"Echeverria P, Dran G, Pereda G, Rico AI, Requena JM, Alonso C, et al. Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination. Immunol Lett. 2001;76:107\u201310.","journal-title":"Immunol Lett"},{"key":"3362_CR24","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1016\/j.vaccine.2006.02.039","volume":"24","author":"PC Echeverria","year":"2006","unstructured":"Echeverria PC, de Miguel N, Costas M, Angel SO. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine. 2006;24:4102\u201310.","journal-title":"Vaccine"},{"key":"3362_CR25","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3748\/wjg.v11.i19.2858","volume":"11","author":"HT Li","year":"2005","unstructured":"Li HT, Yan JB, Li J, Zhou MH, Zhu XD, Zhang YX, et al. Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice. World J Gastroenterol. 2005;11:2858\u201363.","journal-title":"World J Gastroenterol"},{"key":"3362_CR26","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1128\/CVI.00160-09","volume":"16","author":"X Gong","year":"2009","unstructured":"Gong X, Gai W, Xu J, Zhou W, Tien P. Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24. Clin Vaccine Immunol. 2009;16:1595\u2013600.","journal-title":"Clin Vaccine Immunol"},{"key":"3362_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virusres.2012.04.011","volume":"167","author":"C Chen","year":"2012","unstructured":"Chen C, Li J, Bi Y, Jia X, Meng S, Sun L, et al. Gp96 enhances the immunogenicity of subunit vaccine of porcine reproductive and respiratory syndrome virus. Virus Res. 2012;167:162\u201372.","journal-title":"Virus Res"},{"key":"3362_CR28","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.vaccine.2013.01.049","volume":"31","author":"C Chen","year":"2013","unstructured":"Chen C, Li J, Bi Y, Yang L, Meng S, Zhou Y, et al. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity. Vaccine. 2013;31:1838\u201347.","journal-title":"Vaccine"},{"key":"3362_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-3083.2011.02620.x","volume":"75","author":"E Mohit","year":"2012","unstructured":"Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL\u200a\/6 mouse model. Scand J Immunol. 2012;75:27\u201337.","journal-title":"Scand J Immunol"},{"key":"3362_CR30","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.vaccine.2014.03.045","volume":"32","author":"Y Ju","year":"2014","unstructured":"Ju Y, Fan H, Liu J, Hu J, Li X, Li C, et al. Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine. Vaccine. 2014;32:2703\u201311.","journal-title":"Vaccine"},{"key":"3362_CR31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/IAI.66.1.347-352.1998","volume":"66","author":"AI Rico","year":"1998","unstructured":"Rico AI, Del Real G, Soto M, Quijada L, Martinez-A C, Alonso C, et al. Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu\/nu BALB\/c mice. Infect Immun. 1998;66:347\u201352.","journal-title":"Infect Immun"},{"key":"3362_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0166-6851(94)90033-7","volume":"66","author":"F Velge-Roussel","year":"1994","unstructured":"Velge-Roussel F, Chard\u00e8s T, M\u00e9v\u00e9lec P, Brillard M, Hoebeke J, Bout D. Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Mol Biochem Parasitol. 1994;66:31\u20138.","journal-title":"Mol Biochem Parasitol"},{"key":"3362_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3347\/kjp.1996.34.2.135","volume":"34","author":"HW Nam","year":"1996","unstructured":"Nam HW, Im KS, Baek EJ, Choi WY, Cho SY. Analysis of antigenic domain of GST fused major surface protein (p30) fragments of Toxoplasma gondii. Korean J Parasitol. 1996;34:135\u201341.","journal-title":"Korean J Parasitol"},{"key":"3362_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0020-7519(02)00256-4","volume":"33","author":"E Beghetto","year":"2003","unstructured":"Beghetto E, Spadoni A, Buffolano W, Del Pezzo M, Minenkova O, Pavoni E, et al. Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parasitol. 2003;33:163\u201373.","journal-title":"Int J Parasitol"},{"key":"3362_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","volume":"240","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516\u20138.","journal-title":"Science"},{"key":"3362_CR36","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4049\/jimmunol.165.2.628","volume":"165","author":"G Yap","year":"2000","unstructured":"Yap G, Pesin M, Sher A. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol. 2000;165:628\u201331.","journal-title":"J Immunol"},{"key":"3362_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","volume":"34","author":"CD Dupont","year":"2012","unstructured":"Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol. 2012;34:793\u2013813.","journal-title":"Semin Immunopathol"},{"key":"3362_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","volume":"16","author":"E Petersen","year":"1998","unstructured":"Petersen E, Nielsen HV, Christiansen L, Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine. 1998;16:1283\u20139.","journal-title":"Vaccine"},{"key":"3362_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0161-5890(97)00133-8","volume":"34","author":"F Velge-Roussel","year":"1997","unstructured":"Velge-Roussel F, Moretto M, Buzoni-Gatel D, Dimier-Poisson I, Ferrer M, Hoebeke J, Bout D. Differences in immunological response to a T. gondii protein (SAG1) derived peptide between two strains of mice: effect on protection in T. gondii infection. Mol Immunol. 1997;34:1045\u201353.","journal-title":"Mol Immunol"},{"key":"3362_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.actatropica.2015.07.013","volume":"150","author":"VR S\u00e1nchez","year":"2015","unstructured":"S\u00e1nchez VR, Fenoy IM, Picchio MS, Soto AS, Arcon N, Goldman A, et al. Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection. Acta Trop. 2015;150:159\u201365.","journal-title":"Acta Trop"},{"key":"3362_CR41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/IAI.68.2.969-972.2000","volume":"68","author":"F Velge-Roussel","year":"2000","unstructured":"Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun. 2000;68:969\u201372.","journal-title":"Infect Immun"},{"key":"3362_CR42","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","volume":"11","author":"V Martin","year":"2004","unstructured":"Martin V, Supanitsky A, Echeverria PC, Litwin S, Tanos T, De Roodt AR, et al. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol. 2004;11:704\u201310.","journal-title":"Clin Diagn Lab Immunol"},{"key":"3362_CR43","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1016\/j.vaccine.2008.07.031","volume":"26","author":"AF Cuppari","year":"2008","unstructured":"Cuppari AF, Sanchez V, Ledesma B, Frank FM, Goldman A, Angel SO, et al. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Vaccine. 2008;26:5040\u20135.","journal-title":"Vaccine"},{"key":"3362_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.exppara.2012.02.026","volume":"131","author":"B Dziadek","year":"2012","unstructured":"Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice. Exp Parasitol. 2012;131:133\u20138.","journal-title":"Exp Parasitol"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3362-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3362-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3362-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:09:29Z","timestamp":1694725769000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3362-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3362-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"140"}}